A good essay HERE by John Naughton in The Observer on the rise of unregulated machine learning algorithms. It ends with a thought experiment:
Imagine what it would be like if we gave the pharmaceutical industry the leeway that we currently grant to tech companies. Any smart biochemist working for, say, AstraZeneca, could come up with a strikingly interesting new molecule for, say, curing Alzheimer’s. She would then run it past her boss, present the dramatic results of preliminary experiments to a lab seminar after which the company would put it on the market. You only have to think of the Thalidomide scandal to realise why we don’t allow that kind of thing. Yet it is exactly what the tech companies are able to do with algorithms that turn out to have serious downsides for society.
